An efficient route to β-D-isoxazolidinyl nucleosides via diastereoselective Michael addition of hydroxylamine to unsaturated esters

Journal of Organic Chemistry

Volumn 62, Issue 21, 1997, Pages 7430-7434

  Xiang, Yuejun ^a   Gi, Hung Jang ^a   Niu, Deqiang ^a   Schinazi, Raymond F ^a,b   Zhao, Rang ^a  

^a NEW YORK UNIVERSITY   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ISOXAZOLIDINYL NUCLEOSIDE; HYDROXYLAMINE; NUCLEOSIDE DERIVATIVE; PURINE NUCLEOSIDE; PYRIMIDINE NUCLEOSIDE; UNCLASSIFIED DRUG;

ACETYLATION; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION KINETICS; DRUG SYNTHESIS; ISOMERISM; REDUCTION;

EID: 0030734550     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9710588     Document Type: Article

References (55)

1. For selected reviews, see: (a) Nair, V.; Jahnke, T. S. Antimicrob. Agents Chemother. 1995, 39, 1017. (b) Wilson, L. J.; Hager, M. W.; El-Kattan, Y. A.; Liotta, D. C. Synthesis 1995, 1465. (c) De Clercq, E. AIDS Res. Human Retroviruses, 1992, 8, 119. (d) Huryn, D. M.; Okabe, M. Chem. Rev. 1992, 92, 1745.
2. For selected reviews, see: (a) Nair, V.; Jahnke, T. S. Antimicrob. Agents Chemother. 1995, 39, 1017. (b) Wilson, L. J.; Hager, M. W.; El-Kattan, Y. A.; Liotta, D. C. Synthesis 1995, 1465. (c) De Clercq, E. AIDS Res. Human Retroviruses, 1992, 8, 119. (d) Huryn, D. M.; Okabe, M. Chem. Rev. 1992, 92, 1745.
3. For selected reviews, see: (a) Nair, V.; Jahnke, T. S. Antimicrob. Agents Chemother. 1995, 39, 1017. (b) Wilson, L. J.; Hager, M. W.; El-Kattan, Y. A.; Liotta, D. C. Synthesis 1995, 1465. (c) De Clercq, E. AIDS Res. Human Retroviruses, 1992, 8, 119. (d) Huryn, D. M.; Okabe, M. Chem. Rev. 1992, 92, 1745.
4. For selected reviews, see: (a) Nair, V.; Jahnke, T. S. Antimicrob. Agents Chemother. 1995, 39, 1017. (b) Wilson, L. J.; Hager, M. W.; El-Kattan, Y. A.; Liotta, D. C. Synthesis 1995, 1465. (c) De Clercq, E. AIDS Res. Human Retroviruses, 1992, 8, 119. (d) Huryn, D. M.; Okabe, M. Chem. Rev. 1992, 92, 1745.
5. (a) De Clercq, E. J. Med. Chem. 1995, 38, 2491.
6. (b) Dudley, M. N. J. Infect. Disease 1995, 171 (suppl 2), S99.
7. (c) Johnston, M. I.; Hoth, D. F. Science 1993, 260, 1286.
8. (a) De Clercq, E. Biochem. Pharm. 1994, 47, 155.
9. (b) Richman, D. D. AIDS Patient Care 1994, 8, 317.
10. (c) Johnson, V. A. J. Infect. Disease 1995, 171 (suppl 2), S140.
11. (d) Sommadossi, J.-P. J. Infect. Disease 1995, 171(suppl 2), S88.
12. (e) Chen, C.-H.; Cheng, Y.-C. J. Biol. Chem, 1989, 264, 11934.
13. (f) Schinazi, R. F.; LLoyd, R. M.; Ramanathan, C. S.; Taylor, E. W. Antimicrob. Agents Chemother. 1994, 38, 268.
14. Another popular therapy is to use two drugs concurrently, including the combination of one dideoxynucleoside with another dideoxynucleoside or a nonnucleoside HIV inhibitor. (a) De Clercq, E. Ann. N.Y. Acad. Sci. 1994, 438. (b) Velázquez, S.; Alvarez, R.; SanFélix, A.; Jimeno, M. L.; De Clercq, E.; Balzarini, J.; Camarasa, M. J. J. Med. Chem. 1995, 38, 1641.
15. Another popular therapy is to use two drugs concurrently, including the combination of one dideoxynucleoside with another dideoxynucleoside or a nonnucleoside HIV inhibitor. (a) De Clercq, E. Ann. N.Y. Acad. Sci. 1994, 438. (b) Velázquez, S.; Alvarez, R.; SanFélix, A.; Jimeno, M. L.; De Clercq, E.; Balzarini, J.; Camarasa, M. J. J. Med. Chem. 1995, 38, 1641.
16. For recent examples, see: (a) Jeong, L. S.; Marquez, V. E. Tetrahedron Lett. 1996, 37, 2353. (b) El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890. (c) Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822. (d) Konkel, M. J.; Vince, R. Tetrahedron 1996, 52, 799. (e) Wnuk, S. F.; Robins, M. J. J. Am. Chem. Soc. 1996, 118, 2519. (f) Shaw-Ponter, S.; Mills, G.; Robertson, M.; Bostwick, R. D.; Hardy, G. W.; Young, R. J. Tetrahedron Lett. 1996, 37, 1867. (g) Lin, T.-S.; Luo, M.-L.; Liu, M.-C. Tetrahedron. 1995, 51, 1055.
17. For recent examples, see: (a) Jeong, L. S.; Marquez, V. E. Tetrahedron Lett. 1996, 37, 2353. (b) El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890. (c) Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822. (d) Konkel, M. J.; Vince, R. Tetrahedron 1996, 52, 799. (e) Wnuk, S. F.; Robins, M. J. J. Am. Chem. Soc. 1996, 118, 2519. (f) Shaw-Ponter, S.; Mills, G.; Robertson, M.; Bostwick, R. D.; Hardy, G. W.; Young, R. J. Tetrahedron Lett. 1996, 37, 1867. (g) Lin, T.-S.; Luo, M.-L.; Liu, M.-C. Tetrahedron. 1995, 51, 1055.
18. For recent examples, see: (a) Jeong, L. S.; Marquez, V. E. Tetrahedron Lett. 1996, 37, 2353. (b) El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890. (c) Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822. (d) Konkel, M. J.; Vince, R. Tetrahedron 1996, 52, 799. (e) Wnuk, S. F.; Robins, M. J. J. Am. Chem. Soc. 1996, 118, 2519. (f) Shaw-Ponter, S.; Mills, G.; Robertson, M.; Bostwick, R. D.; Hardy, G. W.; Young, R. J. Tetrahedron Lett. 1996, 37, 1867. (g) Lin, T.-S.; Luo, M.-L.; Liu, M.-C. Tetrahedron. 1995, 51, 1055.
19. For recent examples, see: (a) Jeong, L. S.; Marquez, V. E. Tetrahedron Lett. 1996, 37, 2353. (b) El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890. (c) Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822. (d) Konkel, M. J.; Vince, R. Tetrahedron 1996, 52, 799. (e) Wnuk, S. F.; Robins, M. J. J. Am. Chem. Soc. 1996, 118, 2519. (f) Shaw-Ponter, S.; Mills, G.; Robertson, M.; Bostwick, R. D.; Hardy, G. W.; Young, R. J. Tetrahedron Lett. 1996, 37, 1867. (g) Lin, T.-S.; Luo, M.-L.; Liu, M.-C. Tetrahedron. 1995, 51, 1055.
20. For recent examples, see: (a) Jeong, L. S.; Marquez, V. E. Tetrahedron Lett. 1996, 37, 2353. (b) El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890. (c) Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822. (d) Konkel, M. J.; Vince, R. Tetrahedron 1996, 52, 799. (e) Wnuk, S. F.; Robins, M. J. J. Am. Chem. Soc. 1996, 118, 2519. (f) Shaw-Ponter, S.; Mills, G.; Robertson, M.; Bostwick, R. D.; Hardy, G. W.; Young, R. J. Tetrahedron Lett. 1996, 37, 1867. (g) Lin, T.-S.; Luo, M.-L.; Liu, M.-C. Tetrahedron. 1995, 51, 1055.
21. For recent examples, see: (a) Jeong, L. S.; Marquez, V. E. Tetrahedron Lett. 1996, 37, 2353. (b) El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890. (c) Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822. (d) Konkel, M. J.; Vince, R. Tetrahedron 1996, 52, 799. (e) Wnuk, S. F.; Robins, M. J. J. Am. Chem. Soc. 1996, 118, 2519. (f) Shaw-Ponter, S.; Mills, G.; Robertson, M.; Bostwick, R. D.; Hardy, G. W.; Young, R. J. Tetrahedron Lett. 1996, 37, 1867. (g) Lin, T.-S.; Luo, M.-L.; Liu, M.-C. Tetrahedron. 1995, 51, 1055.
22. For recent examples, see: (a) Jeong, L. S.; Marquez, V. E. Tetrahedron Lett. 1996, 37, 2353. (b) El-Subbagh, H. I.; Racha, S.; Abushanab, E.; Panzica, R. P. J. Org. Chem. 1996, 61, 890. (c) Yoshimura, Y.; Kitano, K.; Satoh, H.; Watanabe, M.; Miura, S.; Sakata, S.; Sasaki, T.; Matsuda, A. J. Org. Chem. 1996, 61, 822. (d) Konkel, M. J.; Vince, R. Tetrahedron 1996, 52, 799. (e) Wnuk, S. F.; Robins, M. J. J. Am. Chem. Soc. 1996, 118, 2519. (f) Shaw-Ponter, S.; Mills, G.; Robertson, M.; Bostwick, R. D.; Hardy, G. W.; Young, R. J. Tetrahedron Lett. 1996, 37, 1867. (g) Lin, T.-S.; Luo, M.-L.; Liu, M.-C. Tetrahedron. 1995, 51, 1055.
23. For selected examples, see: (a) Jeong, L. S.; Schinazi, R, F.; Beach, J. W.; Kim, H. O.; Nampalli, S.; Shanmuganathan, K.; Alves, A. J.; McMillan, A.; Chu, C. K.; Mathis, R. J. Med. Chem. 1993, 36, 181. (b) van Leeuwen, R.; Katlama, C.; Kitchen, V.; Boucher, C. A. B.; Tubiana, R.; McBride, M.; Ingrand, D.; Weber, J.; Hill, A.; McDade, H.; Danner, S. A. J. Infect. Dis. 1995, 171, 1166. (c) Jin, H.; Siddiqui, A.; Evans, C. A.; Tse, H. L. A.; Mansour, T. S. J. Org. Chem. 1995, 60, 2621.
24. For selected examples, see: (a) Jeong, L. S.; Schinazi, R, F.; Beach, J. W.; Kim, H. O.; Nampalli, S.; Shanmuganathan, K.; Alves, A. J.; McMillan, A.; Chu, C. K.; Mathis, R. J. Med. Chem. 1993, 36, 181. (b) van Leeuwen, R.; Katlama, C.; Kitchen, V.; Boucher, C. A. B.; Tubiana, R.; McBride, M.; Ingrand, D.; Weber, J.; Hill, A.; McDade, H.; Danner, S. A. J. Infect. Dis. 1995, 171, 1166. (c) Jin, H.; Siddiqui, A.; Evans, C. A.; Tse, H. L. A.; Mansour, T. S. J. Org. Chem. 1995, 60, 2621.
25. For selected examples, see: (a) Jeong, L. S.; Schinazi, R, F.; Beach, J. W.; Kim, H. O.; Nampalli, S.; Shanmuganathan, K.; Alves, A. J.; McMillan, A.; Chu, C. K.; Mathis, R. J. Med. Chem. 1993, 36, 181. (b) van Leeuwen, R.; Katlama, C.; Kitchen, V.; Boucher, C. A. B.; Tubiana, R.; McBride, M.; Ingrand, D.; Weber, J.; Hill, A.; McDade, H.; Danner, S. A. J. Infect. Dis. 1995, 171, 1166. (c) Jin, H.; Siddiqui, A.; Evans, C. A.; Tse, H. L. A.; Mansour, T. S. J. Org. Chem. 1995, 60, 2621.
26. For selected recent examples, see: (a) Mansour, T. S.; Jin, H.; Wang, W.; Hooker, E. U.; Ashman, C.; Cammack, N.; Salomon, H.; Belmonta, A. R.; Wainberg, M. A. J. Med. Chem. 1995, 1, 1. (b) Liang, C.; Lee, D. W.; Newton, M. G.; Chu, C. K. J. Org. Chem. 1995, 60, 1546. (c) Branalt, J.; Kvarnstrom, I.; Classon, B.; Samuelsson, B. J. Org. Chem. 1996, 61, 3611, and references therein.
27. For selected recent examples, see: (a) Mansour, T. S.; Jin, H.; Wang, W.; Hooker, E. U.; Ashman, C.; Cammack, N.; Salomon, H.; Belmonta, A. R.; Wainberg, M. A. J. Med. Chem. 1995, 1, 1. (b) Liang, C.; Lee, D. W.; Newton, M. G.; Chu, C. K. J. Org. Chem. 1995, 60, 1546. (c) Branalt, J.; Kvarnstrom, I.; Classon, B.; Samuelsson, B. J. Org. Chem. 1996, 61, 3611, and references therein.
28. For selected recent examples, see: (a) Mansour, T. S.; Jin, H.; Wang, W.; Hooker, E. U.; Ashman, C.; Cammack, N.; Salomon, H.; Belmonta, A. R.; Wainberg, M. A. J. Med. Chem. 1995, 1, 1. (b) Liang, C.; Lee, D. W.; Newton, M. G.; Chu, C. K. J. Org. Chem. 1995, 60, 1546. (c) Branalt, J.; Kvarnstrom, I.; Classon, B.; Samuelsson, B. J. Org. Chem. 1996, 61, 3611, and references therein.
29. Graciet, J. C.; Faury, P.; Camplo, M.; Charvet, A. S.; Mourier, N.; Trabaud, C.; Niddam, V.; Simon, V.; Kraus, J. L. Nucleosides Nucleotides 1995, 14, 1379.
30. Tronchet, J. M. J.; Iznaden, M.; Barbalat-Rey, F.; Dhimane, H.; Ricca, A.; Balzarini, J.; De Clercq, E. Eur. J. Med. Chem. 1992, 27, 555.
31. (a) Tronchet, J. M. J.; Iznaden, M.; Barbalat-Rey, F.; Komaromi, I.; Dolatshahi, N.; Bernardinelli, G. Nucleosides Nucleotides 1995, 14, 1737.
32. (b) Leggio, A.; Liguori, A.; Procopio, A.; Siciliano, C.; Giovann, C. S. Tetrahedron Lett. 1996, 37, 1277.
33. The synthesis of 5, which is anticipated to be more difficult than that of 3-4, has not been studied.
34. (a) Xiang, Y.; Chen, J.; Schinazi, R. F.; Zhao, K. Tetrahedron Lett. 1995, 36, 7193.
35. (b) Xiang, Y.; Chen, J.; Schinazi, R. F.; Zhao, K. Bioorg. Med. Chem. Lett. 1996, 6, 1051.
36. (c) Xiang, Y.; Gong, Y.; Zhao, K. Tetrahedron Lett. 1996, 37, 4877.
37. (d) Gi, H.; Xiang, Y.; Schinazi, R.; Zhao, K. J. Org. Chem. 1997, 62, 88.
38. Compound 3 was produced in low ee by using the dipolar cycloaddition of various chiral synthons to vinylthymme. A method for the oxidative conversion of the optically active isoxazolidines to isoxazoline derivatives such as 3 has, however, been developed: Pan, L.; Gi, H.; Zhao, K. J. Org. Chem. Submitted for publication.
39. (a) Socha, D.; Jurczak, M.; Chmielewski, M. Tetrahedron Lett. 1995, 36, 135.
40. (b) Jurczak, M.; Socha, D.; Chmielewski, M. Tetrahedron 1996, 52, 1411.
41. (a) Baldwin, S. W.; Aubé, J. Tetrahedron Lett. 1987, 28, 179.
42. (b) Baldwin, J. E.; Harwood, L. M.; Lombard, M. J. Tetrahedron 1984, 40, 4363.
43. (c) Fountain, K. R.; Erwin, R.; Early, T.; Kerl, H. Tetrahedron Lett. 1975, 3027.
44. For selected examples, see: (a) Fronza, G.; Fuganti, C.; Grasselli, P. Tetrahedron Lett. 1980, 2999. (b) Katsuki, T.; Lee, A. W. M.; Ma, P.; Martin, V. S.; Masamune, S.; Sharpless, K. B.; Tuddenham, D.; Walker, F. J. J. Org. Chem. 1982, 47, 1373. (c) Robina, I.; Gearing, R. P.; Buchanan, J. G.; Wightman, R. H. J. Chem. Soc., Perkin Trans 1 1990, 2622. (d) Patrocinio, V. L, Costa, P. R. R.; Correia, C. R. D. Synthesis 1994, 474, (e) Nagumo, S.; Umezawa, I.; Akiyama, J.; Akita, H. Chem. Pharm. Bull. 1995, 43, 171.
45. For selected examples, see: (a) Fronza, G.; Fuganti, C.; Grasselli, P. Tetrahedron Lett. 1980, 2999. (b) Katsuki, T.; Lee, A. W. M.; Ma, P.; Martin, V. S.; Masamune, S.; Sharpless, K. B.; Tuddenham, D.; Walker, F. J. J. Org. Chem. 1982, 47, 1373. (c) Robina, I.; Gearing, R. P.; Buchanan, J. G.; Wightman, R. H. J. Chem. Soc., Perkin Trans 1 1990, 2622. (d) Patrocinio, V. L, Costa, P. R. R.; Correia, C. R. D. Synthesis 1994, 474, (e) Nagumo, S.; Umezawa, I.; Akiyama, J.; Akita, H. Chem. Pharm. Bull. 1995, 43, 171.
46. For selected examples, see: (a) Fronza, G.; Fuganti, C.; Grasselli, P. Tetrahedron Lett. 1980, 2999. (b) Katsuki, T.; Lee, A. W. M.; Ma, P.; Martin, V. S.; Masamune, S.; Sharpless, K. B.; Tuddenham, D.; Walker, F. J. J. Org. Chem. 1982, 47, 1373. (c) Robina, I.; Gearing, R. P.; Buchanan, J. G.; Wightman, R. H. J. Chem. Soc., Perkin Trans 1 1990, 2622. (d) Patrocinio, V. L, Costa, P. R. R.; Correia, C. R. D. Synthesis 1994, 474, (e) Nagumo, S.; Umezawa, I.; Akiyama, J.; Akita, H. Chem. Pharm. Bull. 1995, 43, 171.
47. For selected examples, see: (a) Fronza, G.; Fuganti, C.; Grasselli, P. Tetrahedron Lett. 1980, 2999. (b) Katsuki, T.; Lee, A. W. M.; Ma, P.; Martin, V. S.; Masamune, S.; Sharpless, K. B.; Tuddenham, D.; Walker, F. J. J. Org. Chem. 1982, 47, 1373. (c) Robina, I.; Gearing, R. P.; Buchanan, J. G.; Wightman, R. H. J. Chem. Soc., Perkin Trans 1 1990, 2622. (d) Patrocinio, V. L, Costa, P. R. R.; Correia, C. R. D. Synthesis 1994, 474, (e) Nagumo, S.; Umezawa, I.; Akiyama, J.; Akita, H. Chem. Pharm. Bull. 1995, 43, 171.
48. For selected examples, see: (a) Fronza, G.; Fuganti, C.; Grasselli, P. Tetrahedron Lett. 1980, 2999. (b) Katsuki, T.; Lee, A. W. M.; Ma, P.; Martin, V. S.; Masamune, S.; Sharpless, K. B.; Tuddenham, D.; Walker, F. J. J. Org. Chem. 1982, 47, 1373. (c) Robina, I.; Gearing, R. P.; Buchanan, J. G.; Wightman, R. H. J. Chem. Soc., Perkin Trans 1 1990, 2622. (d) Patrocinio, V. L, Costa, P. R. R.; Correia, C. R. D. Synthesis 1994, 474, (e) Nagumo, S.; Umezawa, I.; Akiyama, J.; Akita, H. Chem. Pharm. Bull. 1995, 43, 171.
49. 12a Broadly separated chemical shifts were also observed in the methylene groups of the cis isoxazolidines such as 16, 19, and 24.
50. (a) Hildebrand, C.; Wright, G. E. J. Org. Chem. 1992, 57, 1808.
51. (b) Chapeau, M.-C.; Marnett, L. J. J. Org. Chem. 1993, 58, 7258.
52. (c) Sugimura, H.; Osumi, K.; Kodaka, Y.; Sujino, K. J. Org. Chem. 1994, 59, 7653.
53. (a) Vorbrüggen, H.; Höfle, G. Chem. Ber. 1981, 114, 1256, and references therein,
54. (b) Dudyez, L. W.; Wright, G. E. Nucleosides Nucleotides 1984, 3, 33.
55. (c) Garner, P. Ramakanth, S. J. Org. Chem. 1988, 53, 1294.